Subcutaneous botulinum toxin A for the treatment of refractory complex regional pain syndrome.
Department of Physical Medicine and Rehabilitation, University of Kentucky Medical Center, 800 Rose St, Lexington, KY 40536, USA. pravardhanbirthi@gmail.com
Pravardhan
P
Birthi
Paul
P
Sloan
Sara
S
Salles
D000328:Adult; D019274:Botulinum Toxins, Type A / Q000627:therapeutic use*; D020918:Complex Regional Pain Syndromes / Q000175:diagnosis / Q000188:drug therapy*; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D007279:Injections, Subcutaneous; D010147:Pain Measurement; D010148:Intractable Pain / Q000175:diagnosis / Q000188:drug therapy*; D017060:Patient Satisfaction; D012720:Severity of Illness Index; D016896:Treatment Outcome; D034941:Upper Extremity / Q000503:physiopathology
D019274:Botulinum Toxins, Type A